Application

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 02/28/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 90532537

Filing Date: 02/17/2021

To the Commissioner for Trademarks:

MARK: LUMAKRAS (stylized and/or with design, see mark)
The literal element of the mark consists of LUMAKRAS. The applicant is not claiming color as a feature of the mark. The mark consists of LUMAKRAS with half circle design over KRAS.
The applicant, Amgen Inc,, a corporation of Delaware, having an address of
      Trademark Operations - MS-28-5A
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States
      805-447-3278(phone)
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Pharmaceutical preparations for use in the prevention of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, oncology, tumors, solid and hematological tumors and growths, hematological and hemolytic diseases and disorders, including bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for use in the treatment of amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders; pharmaceutical preparations for use in the treatment of solid tumors and growths, hemolytic diseases and disorders, amyloidosis, metabolic diseases and disorders, lupus, and inflammation and autoimmune diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




For informational purposes only, applicant's website address is: www.amgen.com

The owner's/holder's proposed attorney information: Elsa D. Lemoine. Other appointed attorneys are Timothy J. Gaul, Richard V. Person, and Stuart L. Watt. Elsa D. Lemoine of Amgen Inc., is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      Trademark Operations-MS-28-5A
      One Amgen Center Drive
      Thousand Oaks, California 91320-1799
      United States
      805-447-3278(phone)
      elemoine@amgen.com
The docket/reference number is TM-2135-US-1.
Elsa D. Lemoine submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:

Elsa D. Lemoine

PRIMARY EMAIL FOR CORRESPONDENCE: elemoine@amgen.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmops@amgen.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Elsa D. Lemoine/   Date: 02/17/2021
Signatory's Name: Lemoine, Elsa D.
Signatory's Position: Attorney of Record, California Bar member
Signatory's Phone Number: 805-447-3278
Signature method: Sent to third party for signature
Payment Sale Number: 90532537
Payment Accounting Date: 02/17/2021

Serial Number: 90532537
Internet Transmission Date: Wed Feb 17 16:29:12 ET 2021
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2021021716291245
2345-90532537-770185067fd5acf0c0e3397a23
1768e183203bd2cb65f868b1bcd7b930add39-DA
-29123686-20210217122650324630